BANK OF AMERICA CORP /DE/ - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 121 filers reported holding ROCKET PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$6,820,957
-20.5%
332,892
-22.9%
0.00%0.0%
Q2 2023$8,580,680
-18.8%
431,841
-30.0%
0.00%0.0%
Q1 2023$10,571,901
+39.5%
617,157
+59.4%
0.00%0.0%
Q4 2022$7,577,015
+167.6%
387,175
+118.3%
0.00%
Q3 2022$2,831,000
+198.6%
177,383
+157.4%
0.00%
Q2 2022$948,000
-41.2%
68,909
-32.2%
0.00%
Q1 2022$1,611,000
-27.9%
101,563
-0.8%
0.00%
Q4 2021$2,234,000
-62.2%
102,343
-48.3%
0.00%
-100.0%
Q3 2021$5,917,000
-62.5%
197,967
-44.4%
0.00%
-50.0%
Q2 2021$15,771,000
-32.9%
356,094
-32.8%
0.00%
-33.3%
Q1 2021$23,503,000
-24.3%
529,730
-6.4%
0.00%
-25.0%
Q4 2020$31,050,000
+103.0%
566,206
-15.4%
0.00%
+100.0%
Q3 2020$15,292,000
+63.8%
668,967
+50.0%
0.00%
+100.0%
Q2 2020$9,333,000
+132.9%
445,932
+55.3%
0.00%0.0%
Q1 2020$4,007,000
+836.2%
287,222
+1425.8%
0.00%
Q4 2019$428,000
-80.8%
18,824
-90.1%
0.00%
Q3 2019$2,224,000
+59.5%
190,824
+105.3%
0.00%
Q2 2019$1,394,000
+35.1%
92,936
+57.9%
0.00%
Q1 2019$1,032,000
+72.6%
58,870
+45.9%
0.00%
Q4 2018$598,000
-31.2%
40,360
+14.4%
0.00%
Q3 2018$869,000
+534.3%
35,271
+405.1%
0.00%
Q2 2018$137,000
-4.9%
6,983
-9.0%
0.00%
Q1 2018$144,0007,6730.00%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
M28 Capital Management LP 715,880$9,851,00011.04%
RTW INVESTMENTS, LP 15,802,802$217,447,0005.62%
Amitell Capital Pte Ltd 97,331$1,339,0003.05%
Prosight Management, LP 276,802$3,809,0003.00%
TANG CAPITAL MANAGEMENT LLC 1,265,900$17,419,0002.64%
Affinity Asset Advisors, LLC 250,466$3,446,0001.45%
COWEN AND COMPANY, LLC 1,000,000$13,760,0001.33%
Boxer Capital, LLC 1,466,051$20,173,0001.28%
Cormorant Asset Management, LP 868,550$11,951,0000.90%
MAVERICK CAPITAL LTD 2,532,366$34,845,0000.86%
View complete list of ROCKET PHARMACEUTICALS INC shareholders